x
Filter:
Filters applied
- EMAS Position Statements and Clinical Guides
- Schenck-Gustafsson, KarinRemove Schenck-Gustafsson, Karin filter
- Palacios, SantiagoRemove Palacios, Santiago filter
Author
- Erel, C Tamer2
- Lambrinoudaki, Irene2
- Rees, Margaret2
- Tremollieres, Florence2
- Birkhauser, Martin1
- Borrego, Rafael Sanchez1
- Brincat, Mark1
- Ceausu, Iuliana1
- Depypere, Herman1
- Gambacciani, Marco1
- Llaneza, Placido1
- Moen, Mette H1
- Neves-e-Castro, Manuel1
- Pérez-López, Faustino R1
- Rozenberg, Serge1
- Samsioe, Goran1
- Simoncini, Tommaso1
- van der Schouw, Yvonne T1
- Vujovic, Svetlana1
EMAS Position Statements and Clincial Guides
2 Results
- Research Article
EMAS position statement: The ten point guide to the integral management of menopausal health
MaturitasVol. 81Issue 1p88–92Published online: February 10, 2015- Manuel Neves-e-Castro
- Martin Birkhauser
- Goran Samsioe
- Irene Lambrinoudaki
- Santiago Palacios
- Rafael Sanchez Borrego
- and others
Cited in Scopus: 67With increased longevity and more women becoming centenarians, management of the menopause and postreproductive health is of growing importance as it has the potential to help promote health over several decades. Women have individual needs and the approach needs to be personalised. The position statement provides a short integral guide for all those involved in menopausal health. It covers diagnosis, screening for diseases in later life, treatment and follow-up. - Research Article
EMAS clinical guide: Selective estrogen receptor modulators for postmenopausal osteoporosis
MaturitasVol. 71Issue 2p194–198Published online: November 24, 2011- Santiago Palacios
- Mark Brincat
- C. Tamer Erel
- Marco Gambacciani
- Irene Lambrinoudaki
- Mette H. Moen
- and others
Cited in Scopus: 16Osteoporosis and the resulting fractures are major public health issues as the world population is ageing. Various therapies such as bisphosphonates, strontium ranelate and more recently denosumab are available. This clinical guide provides the evidence for the clinical use of selective estrogen modulators (SERMs) in the management of osteoporosis in postmenopausal women.
